These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26452055)

  • 1. Subcutaneous Dissemination from an Orbital Diffuse Large B Cell Lymphoma.
    Bains S; Vidhya N; Kim U; Shanti R; Devanand J
    Orbit; 2015; 34(6):338-9. PubMed ID: 26452055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orbital signet-ring cell lymphoma of diffuse, large, B-cell type.
    Mulay K; Nair AG; Aggarwal E; White VA; Honavar SG
    Can J Ophthalmol; 2013 Dec; 48(6):e156-8. PubMed ID: 24314431
    [No Abstract]   [Full Text] [Related]  

  • 3. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
    Morley AM; Verity DH; Meligonis G; Rose GE
    Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challenges.
    Wobser M; Kneitz H; Bröcker EB; Becker JC
    J Dtsch Dermatol Ges; 2011 Mar; 9(3):204-11. PubMed ID: 21122066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous plasmablastic lymphoma.
    Jambusaria A; Shafer D; Wu H; Al-Saleem T; Perlis C
    J Am Acad Dermatol; 2008 Apr; 58(4):676-8. PubMed ID: 18342714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diffuse large B-cell lymphoma mimicking Wegener's granulomatosis].
    Gawryluk D; Słodkowska J; Dobkowski P; Wiatr E
    Pneumonol Alergol Pol; 2002; 70(3-4):210-5. PubMed ID: 12271968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
    Posada García C; Florez A; Pardavila R; Garcia-Cruz A; Amador L; Alvarez M; Alberte LM; Cruces MJ
    Eur J Dermatol; 2009; 19(4):394-5. PubMed ID: 19467966
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrophage colony-stimulating factor produced by diffuse large B-cell lymphoma.
    Nakayama-Ichiyama S; Yokote T; Oka S; Takubo T; Tsuji M; Hanafusa T
    Br J Haematol; 2010 May; 149(3):310. PubMed ID: 20085576
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary cutaneous diffuse large B cell lymphoma, leg type.
    Dongre A; Kar S; Gondse S; Gangane N; Mehra BK
    Indian J Dermatol Venereol Leprol; 2011; 77(2):212-4. PubMed ID: 21393962
    [No Abstract]   [Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma with germinal center B-cell phenotype mimicking primary effusion lymphoma.
    Lim Y; Kim TY; Choi IS; Kim BS; Lee TS; Kim JE; Chang MS; Kim KH
    J Clin Oncol; 2011 Apr; 29(10):e271-3. PubMed ID: 21220599
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary cutaneous follicle centre lymphoma: report of a case].
    Rong YF; He LM; Zhang YS; Feng YZ
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):769-70. PubMed ID: 24447559
    [No Abstract]   [Full Text] [Related]  

  • 13. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: report of a case in the oral cavity.
    Jaradat JM; Potluri A; Bilodeau EA
    Indian J Dent Res; 2013; 24(3):384-6. PubMed ID: 24025890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
    Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
    Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case for diagnosis.
    Salaro CP; Tchernev G
    An Bras Dermatol; 2011; 86(4):817-8. PubMed ID: 21987160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is your diagnosis? Cutaneous B-cell lymphoma.
    Carlson SW; Aneja S; Honda K; Cooper KD
    Cutis; 2014 Nov; 94(5):217, quiz 249-51. PubMed ID: 25474456
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
    Huang HC; Cheng AL; Lin CW; Kuo SH
    Ann Hematol; 2013 Jul; 92(7):989-92. PubMed ID: 23242476
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
    Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
    Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
    Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
    Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
    [No Abstract]   [Full Text] [Related]  

  • 20. 18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma.
    Odawara J; Asada N; Aoki T; Yamakura M; Takeuchi M; Ohuchi T; Matsue K
    Br J Haematol; 2007 Mar; 136(5):684. PubMed ID: 17129231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.